61MA.F MEDCAP AB SK-40

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
49.44 EUR
Close of Nov 11, 2026
41.20 53.55
Market cap
EUR 740M
P/E
30.0x
P/B
4.79x
ROE
16.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 61MA.F undervalued?

Graham number
Price49.44
Graham value19.58
Premium152.5%

61MA.F trades 152.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

MEDCAP AB SK-40 fundamental analysis

No fundamental analysis for MEDCAP AB SK-40 yet.

MEDCAP AB SK-40 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About MEDCAP AB SK-40

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals; MedTech including healthcare equipment, software, components, and packaging solutions for life science products; and Assistive Tech including digital and physical solutions in cognition, communic…

Full company profile